Spatial-Ready Tissue Microarray (TMA) Design: How to Screen Multiple Research Tissue Cores on a Shared Spatial Capture Area

For research use only. Not intended for clinical diagnosis, treatment, or individual health assessment.
Spatially resolved transcriptomics maps gene expression within intact histological architecture, but capture-area consumables and per-slide processing can limit cohort scale. Mounting one research specimen per active area may use substantial capacity when the tissue occupies only a small part of the available frame. A spatial-ready tissue microarray (TMA) can consolidate compatible research cores, provided that tissue representation, RNA quality, layout, and analytical separation are planned in advance.
Mounting individual specimens across separate slides can also introduce slide-to-slide variation in permeabilization, probe handling, and imaging. By assembling multiple compatible cores in one recipient block, a spatial-ready TMA can increase the number of research specimens processed within a capture area and reduce, but not eliminate, some inter-slide variation. The achievable core count and per-sample saving depend on core diameter, spacing, capture geometry, platform, repeat sections, failed-core allowance, and the agreed quotation. Foundational histology and mounting considerations are detailed in our spatial transcriptomics sample prep pitfalls field guide.
This technical guide establishes an operational framework for designing, constructing, sectioning, and computationally de-multiplexing spatial-ready TMAs. We evaluate core diameter selection models, address the biophysical thermodynamics of multi-donor paraffin fusion, present microtome sectioning protocols that prevent core detachment, and demonstrate how our dedicated spatial tissue microarray construction service and 10x Visium HD spatial transcriptomics service accelerate high-throughput translational cohorts.
TMA Suitability and Tissue Sampling
Why Use Spatial TMAs
The primary justification for engineering a spatial-ready TMA is to use capture area efficiently while processing multiple research specimens under more comparable conditions.
In a conventional workflow, one anatomical section may occupy a full capture frame. For a multi-sample research cohort, this can require many independent capture areas. The number of biological replicates needed is study-specific and should be determined from the design, expected variability, endpoint, and statistical model rather than a universal sample-count rule.
In contrast, a spatial-ready TMA consolidates multiple representative tissue cores into a compact grid. Depending on capture geometry and core diameter, a layout may accommodate dozens of cores in one run. Cores on the same section undergo shared processing, which can reduce selected technical differences, but donor-block quality, core composition, local tissue thickness, and edge effects can still create variation. Cost reduction should therefore be calculated from the final layout and quotation rather than presented as a fixed percentage. For broader background on multi-tissue multiplexing concepts, see our resource on tissue multiplexing in spatial transcriptomics.
Core Diameter Selection
Selecting the tissue core diameter balances sample capacity against anatomical representation. Table 1 provides illustrative planning ranges; the final layout must be checked against the current platform's usable capture geometry, fiducials, section expansion, and required margins.
Figure 2. Illustrative spatial capture layouts comparing several core diameters. Final capacity depends on usable capture geometry, spacing, margins, and tissue expansion.
| Core Punch Diameter | Cross-Sectional Area | Max Cores on 6.5 × 6.5 mm Chip | Max Cores on 11 × 11 mm Chip | Optimal Research Application |
|---|---|---|---|---|
| 0.6 mm Core | ~0.28 mm² (~700 μm actual) | 24–32 cores (5 × 5 to 6 × 6 grid) | 64–80 cores (8 × 8 to 9 × 9 grid) | Homogeneous tumors, high-density biobank screening, cell lines |
| 1.0 mm Core | ~0.79 mm² (~1,150 μm actual) | 12–16 cores (3 × 4 to 4 × 4 grid) | 36–48 cores (6 × 6 to 7 × 7 grid) | Heterogeneous solid tumors (captures invasive margin + tumor core) |
| 1.5 mm Core | ~1.77 mm² (~1,700 μm actual) | 4–6 cores (2 × 2 to 2 × 3 grid) | 16–20 cores (4 × 4 to 4 × 5 grid) | Complex anatomical tissues (lymph node follicles, brain cortex layers) |
For most translational oncology cohorts, the 1.0 mm core punch represents the optimal compromise. A 1.0 mm core possesses sufficient surface area to span the critical tumor-stroma invasive margin, capturing tumor parenchyma, infiltrating cytotoxic T lymphocytes, cancer-associated fibroblasts, and tertiary lymphoid structures in a single punch. When studying highly homogeneous lesions or performing massive target validation across large repositories, 0.6 mm cores maximize donor density, allowing up to 48 cores on an 11 mm chip. Conversely, organs with broad macroscopic architecture (such as layered mammalian cerebral cortex or organized lymphoid follicles) require 1.5 mm cores to capture complete multicellular functional units.
Select Regions Before Choosing Core Capacity
Begin with the biological comparison and review the donor-section image before deciding how many cores to place in the array. A central tumor region, an invasive interface, and a stromal compartment answer different questions even when they come from the same block. Record which compartment each planned core is intended to represent and whether necrosis, folds, or depleted material could compromise it. When an endpoint depends on a broad tissue boundary, consider whether a larger section is more informative than maximizing core density.
Multiple cores from one specimen can help describe regional heterogeneity, but they are nested observations from that specimen rather than independent biological replicates. Keep donor, block, region, and core identifiers separate in the sample sheet. Define whether the analysis will combine cores, compare regions within a donor, or use a model that accounts for the donor structure. This distinction should be settled before punching, because the layout determines which biological comparisons remain possible after the tissue has been consumed.
Array Construction and Section Quality
Array Layout Engineering
Constructing a spatial-ready TMA requires far greater engineering precision than building standard clinical pathology TMAs intended solely for immunohistochemistry (IHC).
First, assess paraffin and block compatibility. Donor blocks can differ in wax formulation, age, hardness, and processing history. Large differences between donor and recipient blocks may contribute to core movement, cracking, or uneven sectioning. The histology laboratory should select a compatible recipient-block formulation and validate any re-embedding or annealing step; a single wax grade or melting-point range is not universal.
Second, define an inter-core margin that remains separable after punching, sectioning, flotation, and image registration. The required spacing depends on core diameter, recipient-block stability, section behavior, platform resolution, and demultiplexing method. Validate the planned grid on a test section instead of treating 200 to 300 μm as a universal minimum.
Third, use asymmetric orientation features when the grid could be confused after rotation. A blank position, a dedicated control core, or another reviewed landmark can support orientation and donor mapping. The choice should avoid consuming scarce tissue unnecessarily and should be documented in the layout map before sectioning.
Balance Groups and Preserve the Layout Record
When several arrays or slides are needed, avoid placing every specimen from one research group on one slide and every comparator on another. Distribute compatible groups across processing units where practical, while respecting tissue quality and handling constraints. Record array position and processing batch as distinct metadata fields so potential position effects and batch effects can be reviewed separately. Retain a versioned layout map connecting every physical location to the donor and region.
Plan how a missing or detached core will be handled before sectioning begins. Review the availability of neighboring sections, backup regions, and replacement material without assuming that every damaged core can be recovered. Record morphology review at the level of the actual assay section: an intact core in an earlier section may not be intact at the level used for profiling. Any revised layout or replacement should remain linked to the original sample identifiers and the final analysis inventory.
Sectioning and Flotation Protocol
Microtomy of a composite block containing 30 or more distinct tissue cores is inherently challenging because different organ cores possess disparate physical hardness (e.g., dense collagenous stroma versus soft adipose tissue).
Figure 3. Key sectioning, flotation, orientation, and slide-transfer checkpoints for spatial TMAs. Exact settings should follow the validated histology and assay workflow.
Composite TMA blocks often require temperature conditioning before microtomy, but the setting and duration depend on paraffin formulation, block hardness, core composition, and microtome conditions. Avoid uncontrolled thermal shock and validate the conditioning procedure with the histology laboratory rather than applying one universal time and temperature.
Section thickness, blade selection, flotation temperature, and section-face orientation must follow the assay and histology laboratory's validated SOP. A 5 μm FFPE section is common in several workflows, but it is not universal. Where the laboratory uses the "B-Side" convention, the specified face is maintained consistently during flotation and slide transfer. Any ethanol pre-relaxation step should likewise be validated for the tissue and slide chemistry.
After placement, drying, baking, and storage conditions should match the platform protocol. Consecutive sections can support morphology review, spatial capture, and backup analysis, but the exact order and number of sections should be defined before cutting to preserve limited material.
Core-Aware Analysis and Cost Review
Computational Demultiplexing
Once sequencing is complete, the single high-dimensional spatial dataset must be computationally segmented and de-multiplexed into discrete donor-specific expression matrices.
The computational pipeline begins with high-resolution H&E image registration. Using platform software and downstream analysis tools, bioinformaticians define digital regions corresponding to each physical core. Spatial barcodes or bins within a reviewed core boundary are assigned to that core's research metadata, while blank paraffin margins are excluded. This reduces boundary mixing but does not by itself prove zero cross-contamination; folds, detached fragments, registration error, and closely spaced cores still require visual and computational QC.
Following digital de-multiplexing, individual core datasets undergo single-cell deconvolution (using tools like RCTD, Cell2location, or CytoSPACE) to resolve local cell-type compositions, coupled with spatial niche differential expression via Niche-DE. When donor biopsies contain regional micro-anatomical niches of interest, investigators frequently combine TMA screening with targeted isolation using our tissue microregion retrieval services, while cellular boundary modeling is supported by our resource on cell segmentation in spatial transcriptomics. Complete downstream analytics are delivered through our spatial transcriptomics data analysis service.
Figure 4. Computational demultiplexing architecture. Spatial barcodes are segmented by reviewed core boundaries, filtered for paraffin margins, and assigned to research-sample metadata for cohort-scale comparison.
Calculate Cost per Usable Biological Sample
For project planning, distinguish nominal capacity from usable study output. The number of holes in a recipient block is not the number of biological samples that pass section review, yield interpretable data, and contribute to the planned contrast. An illustrative costing worksheet can divide the scoped total cost by the number of biological samples meeting the agreed acceptance criteria. Include block construction, morphology review, repeat sections, assay processing, sequencing or imaging, core assignment, and the specified analysis rather than using capture consumables alone.
Maintain a core-status table showing expected, present, detached, excluded, and analyzed cores, with the reason for each exclusion. Review whether losses are concentrated in one group or tissue type before making cohort-level comparisons. Extra cores can provide regional coverage or backup material, but their value depends on representation and usable data rather than packing density. Comparing layouts on this basis supports a transparent discussion of cost, sample consumption, and the strength of the final biological comparison.
Conclusion
A spatial-ready tissue microarray can improve capture-area utilization, but its value depends on representative sampling and disciplined block engineering. The central planning points are:
- Protect biological representation. Core number, diameter, and anatomical selection should reflect tissue heterogeneity and the comparisons defined in the study.
- Design the grid around the capture geometry. Core spacing, edge margins, fiducial orientation, failed-core allowance, and repeat sections should be resolved before punching.
- Control composite-block sectioning risk. Donor-block compatibility, paraffin behavior, core hardness, section thickness, flotation, adhesion, and storage require a validated histology workflow.
- Plan core-aware analysis. Image registration, reviewed core boundaries, blank-margin filtering, sample metadata, and boundary QC are needed to separate donor-specific outputs; a shared slide does not eliminate every source of variation.
CD Genomics supports research-use spatial TMA projects with histological region review, layout design, core punching, recipient-block construction, spatial profiling, and core-aware analysis. Researchers can combine our spatial tissue microarray construction service, 10x Visium HD spatial transcriptomics service, and spatial transcriptomics data analysis service according to project scope and sample suitability. All services and deliverables are provided strictly for research use only and are not intended for clinical diagnosis, treatment, or individual health assessment.
Frequently Asked Questions
References
- Lee D, Cook S, Jung Y, Lim M, et al. Abstract 4948: Automated tumor microenvironment analysis for multiple samples by image-based spatial transcriptomics on tissue microarray. Cancer Research. 2024;84(6_Suppl):4948.
- Ma H, Zhang X, Qu Y, Zhang A, et al. Vispro improves imaging analysis for Visium spatial transcriptomics. Genome Biology. 2025;26(1):112.
- Hudson W, Sudmeier L. Localization of T cell clonotypes using the Visium spatial transcriptomics platform. STAR Protocols. 2022;3(2):101391.
- Li Z, Zhang X, Sun C, Li Z, et al. Integrating microarray-based spatial transcriptomics and RNA-seq reveals tissue architecture in colorectal cancer. Journal of Big Data. 2024;11(1):145.
- Wang H, Huang R, Nelson J, Gao C, Tran M, Yeaton A, et al. Systematic benchmarking of imaging spatial transcriptomics platforms in FFPE tissues. Nature Communications. 2025;16:9899.
- Varrone M, Tavernari D, Santamaria-Martínez A, et al. CellCharter reveals spatial cell niches associated with tissue remodeling and cell plasticity. Nature Genetics. 2024;56:74-84.
- Mason K, Sathe A, Hess PR, et al. Niche-DE: niche-differential gene expression analysis in spatial transcriptomics data identifies context-dependent cell-cell interactions. Genome Biology. 2024;25(1):14.